Here are four notes:
1. Mizuho has a $71.00 price target on AmSurg shares.
2. The firm’s target price suggests a 5.48 percent potential upside from AmSurg’s previous closing.
3. On Nov. 2, 2016, Wells Fargo & Co. rated AmSurg shares an “outperform” rating.
4. During the third quarter of fiscal year 2016, AmSurg had $1.13 earnings per share.
More articles on surgery centers:
Methodist Center for Diagnostic Imaging opens with 1st high-field open MRI in Dallas: 4 key notes
BayCare Health System considers building new outpatient facility — 4 notes
Christ Hospital Health Network still awaiting CON approval for $24M ASC — 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
